In-vivo studies on Transitmycin, a potent Mycobacterium tuberculosis inhibitor.
Mondal R, Dusthackeer V N A, Kannan P, Singh AK, Thiruvengadam K, Manikkam R, A S S, Balasubramanian M, Elango P, Ebenezer Rajadas S, Bharadwaj D, Arumugam GS, Ganesan S, Kumar A K H, Singh M, Patil S, U C A J, Doble M, R B, Tripathy SP, Kumar V.
Mondal R, et al. Among authors: arumugam gs.
PLoS One. 2023 Mar 3;18(3):e0282454. doi: 10.1371/journal.pone.0282454. eCollection 2023.
PLoS One. 2023.
PMID: 36867599
Free PMC article.